Noting that nearly all coronavirus deaths now are among the tens of millions of people who haven't received shots, despite widespread vaccine availability, Dr. Vivek Murthy painted an unsettling picture of what the future could hold.
America is awash with vaccine options, and Novavax does not plan to file for regulatory authorizations until late July at the earliest. The delay could have dire consequences for people across the globe awaiting a vaccine.
Pandemic restrictions on Florida-based cruise ships will remain in place after a federal appeals court temporarily blocked a previous ruling that sided with a Florida lawsuit challenging the regulations.
Consolidating less-used facilities, bundling lease negotiations with landlords and grouping complementary services could reduce costs, JLL experts said.
As this $9 billion industry matures, payers should look beyond FDA approval when reviewing the efficacy of digital tools, with a federal imprimatur becoming solely a decision about how to market a product.
Unvaccinated Americans account for an overwhelming majority of new COVID-19 hospitalizations, the AAMC's CEO said.
Pfizer announced U.S. regulators have agreed to a “priority review” of whether its COVID-19 vaccine should be fully approved, with a decision set for no later than January.
The Biden administration's plan to overhaul Obamacare marketplace waivers could help states expand coverage. But states could be left holding the bag if they enroll too many people.
Healthcare organizations can apply for American Rescue Plan funding through HHS to address employee burnout and build workforce resiliency.
Congressional Democrats' plan to cover 2 million people in the Medicaid expansion gap would be a big help for rural hospitals at risk of closure.
Tens of thousands of times a year, hospitals charge enormously expensive trauma alert fees for injuries so minor the patient is never admitted.
